New Agents Show Promise for Severe and Fatal Genetic Disease

Hereditary transthyretin amyloidosis is caused by mutation in the TTR gene. Two promising new agents may slow the progression and improve the symptoms of this progressive and fatal disease.
Medscape Medical News